FdaApplication
BLA 022505
Identifiers
- fda_app_no: BLA022505
Properties
| Property | Value |
|---|---|
| applicant_name | Theratechnologies Inc. |
| application_type | BLA |
| approval_date | 2010-11-10 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EGRIFTA SV | TESAMORELIN ACETATE | 2MG | For Injection |
| EGRIFTA | TESAMORELIN ACETATE | 1MG | For Injection |
| EGRIFTA WR | — | 11.6MG | For Injection |
3 products